Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Baxter
McKesson
Medtronic
Dow

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Gemcabene


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Gemcabene?

Gemcabene is an investigational drug.

There have been 12 clinical trials for Gemcabene. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2000.

The most common disease conditions in clinical trials are Hypercholesterolemia, Hypertriglyceridemia, and Non-alcoholic Fatty Liver Disease. The leading clinical trial sponsors are Gemphire Therapeutics, Inc., NeuroBo Pharmaceuticals Inc., and Gemphire Therapeutics.

Recent Clinical Trials for Gemcabene
TitleSponsorPhase
Gemcabene for the Treatment of Pediatric NAFLDGemphire TherapeuticsPhase 2
Gemcabene for the Treatment of Pediatric NAFLDGemphire Therapeutics, Inc.Phase 2
Gemcabene for the Treatment of Pediatric NAFLDEmory UniversityPhase 2

See all Gemcabene clinical trials

Clinical Trial Summary for Gemcabene

Top disease conditions for Gemcabene
Top clinical trial sponsors for Gemcabene

See all Gemcabene clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Baxter
McKesson
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.